COMPARISON OF HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, 2 ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES

被引：118

作者：

ALLEN, LM ^{[1
]}

CREAVEN, PJ ^{[1
]}

机构：

[1] VET ADM HOSP, NCI, MED ONCOL BRANCH, ONCOL PHARMACOL SECT, WASHINGTON, DC 20422 USA

来源：

关键词：

D O I：

10.1016/0014-2964(75)90043-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：697 / 707

页数：11

共 54 条

[41] NISSEN NI, 1972, CANCER CHEMOTH REP 1, V56, P769
[42] RESCIGNO A, 1966, DRUG TRACER KINETICS
[43] ROWLAND M, 1970, Journal of Pharmaceutical Sciences, V59, P364, DOI 10.1002/jps.2600590319
[44] SAVEL H, 1966, PROG EXP TUMOR RES, V8, P189
[45] SKLANSKY BD, 1974, CANCER-AM CANCER SOC, V33, P460, DOI 10.1002/1097-0142(197402)33:2<460::AID-CNCR2820330222>3.0.CO
[46] 2-5
[47] SOLOMON HM, 1971, CLIN PHARMACOL THER, V12, P445
[48] EXPERIENCE WITH 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-2-THENYLIDENE-BETA-D-GLUCOPYRANOSIDE) - VM-26 - NSC-122819 IN TREATMENT OF MALIGNANT LYMPHOSIS
SONNTAG, RW
SENN, HJ
NAGEL, G
GIGER, K
ALBERTO, P
[J]. EUROPEAN JOURNAL OF CANCER, 1974, 10 (02) : 93 - 98
[49] 4'-DEMETHYL-EPIPODOPHYLLOTOXIN THENYLIDENE GLUCOSIDE (VM 26), A PODOPHYLLUM COMPOUND WITH A NEW MECHANISM OF ACTION
STAHELIN, H
[J]. EUROPEAN JOURNAL OF CANCER, 1970, 6 (04) : 303 - +
[50] ACTIVITY OF A NEW GLYCOSIDIC LIGNAN DERIVATIVE (VP 16-213) RELATED TO PODOPHYLLOTOXIN IN EXPERIMENTAL TUMORS
STAHELIN, H
[J]. EUROPEAN JOURNAL OF CANCER, 1973, 9 (03) : 215 - 221